Medtronic, Inc. (MDT) PT Raised to $94 at Barclays; Reiterates Overweight
Tweet Send to a Friend
Barclays raised its price target on Medtronic, Inc. (NYSE: MDT) to $94.00 (from $92.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


